Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose bioequivalence study of generic dabigatran etexilate vs Pradaxa in healthy Thai volunteers (fasting)
TCTR20230427002Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dabigatran in venous thromboembolism (VTE), Atrial fibrillation (AFib), deep vein thrombosis (DVT) and 1 more (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on TCTR20230427002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230427002.